Satofuka, Hiroyuki
Wang, Yayan
Yamazaki, Kyotaro
Hamamichi, Shusei
Fukuhara, Takeshi
Rafique, Abdur
Osako, Nana
Kanazawa, Iori
Endo, Takeshi
Miyake, Naomi
Honma, Kazuhisa
Nagashima, Yuichi
Hichiwa, Genki
Shimoya, Kazuto
Abe, Satoshi
Moriwaki, Takashi
Murakami, Yasufumi
Gao, Xu
Kugoh, Hiroyuki
Oshimura, Mitsuo
Ito, Yuji
Kazuki, Yasuhiro
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP22gm1610006, JP21am0101124)
Core Research for Evolutional Science and Technology (JPMJCR18S4)
Article History
Received: 28 July 2022
Accepted: 8 March 2023
First Online: 14 March 2023
Competing interests
: M.O. is a CEO, employee, and shareholder of Trans Chromosomics, Inc., and I.K., T.E., and S.A. are employees of Trans Chromosomics, Inc. The remaining authors declare no conflicts of interest.